BioSpace News Archive

Catamaran Bio , Inc. today announced the appointment of Michael DeRidder, PhD, as Senior Vice President, Corporate Strategy and New Product Planning.

Instrumems announced its formal entry into the flow sensor market with a breakthrough solution that offers multi-sense capabilities.

Minerva Neurosciences, Inc. today announced that results from the Phase 3 clinical trial of roluperidone to treat negative symptoms in patients with schizophrenia have been published in Schizophrenia Bulletin.

ALR Technologies Inc., the diabetes management company, announced preliminary results from the Non-Inferiority Study currently being conducted on the GluCurve Pet CGM.

Ra Medical Systems, Inc. (NYSE American: RMED), announces the filing of a 510(k) application with the U.S. Food and Drug Administration (FDA) for the company’s next-generation DABRA catheter with a braided overjacket and a six-month shelf life as a device for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and with an intended use for ablating a channel in occlusive peripheral vascular disease.

Gemini Therapeutics, Inc., a clinical stage precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration, provided a corporate update announcing a leadership transition, strategic evaluation and corporate restructuring.

Progenity, Inc., a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, announced the acceptance of three abstracts on the treatment of IBD and microbiome sampling for presentation at Digestive Disease Week®.

Elektrofi announced it has entered into a contract with the Defense Health Agency Small Business Innovation Research Program within the Department of Defense focused on exploring the company’s platform formulation technology for the delivery of prefilled, high-dose formulations for the rapid deployment of antibody treatments for COVID-19 and pandemic preparation.

Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announced it has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for Oleogel-S10.

RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, today announces a new tool for Total Shoulder Arthroplasty (TSA) planning.